M-LEVETIRACETAM

mantra pharma inc🇨🇦 Health Canada

Approval Id: a2c970734e2b8cdb
Drug Approval Canada Name: M-LEVETIRACETAM
Product Name: M-LEVETIRACETAM
Status: Marketed
Status Date: 2022-08-23
Original Market Date: 2022-08-23
Din: 02524562
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N03AX14 LEVETIRACETAM
Atc Name: n 03 ax 14
Aig Number: 0148843001
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

LEVETIRACETAM

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a2c970734e2b8cdb

Type

Standard